Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

News Conference News AHA 2016

AHA/ACC Issue Updated PAD Guidelines

L.A. McKeown

November 14, 2016

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

L.A. McKeown

October 05, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

Presentation TCT 2014

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Lawrence A. Garcia

September 15, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Daily News

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Caitlin E. Cox

June 28, 2013

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

Small Trial Shows Promise of Cell Therapy in Critical Limb Ischemia

Jason Kahn

October 31, 2011

News Daily News

Cell Therapy Trials Show Safety, Efficacy Signal in Critical Limb Ischemia

January 25, 2011

Advertisement

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

AHA/ACC Issue Updated PAD Guidelines

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Small Trial Shows Promise of Cell Therapy in Critical Limb Ischemia

Cell Therapy Trials Show Safety, Efficacy Signal in Critical Limb Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content